{"page_content": "Share price performance\nThe price of Zealand\u2019s shares decreased by 34.2% during 2021 with a market closing share price at year-end of DKK 145.1, compared to DKK 220.6 at year-end 2020.\nAnnual General Meeting\nThe annual general meeting is scheduled to be held elec-tronically on Wednesday, April 6, 2022 at 3:00 PM CET. Additional information will become available at https://www.zealandpharma.com/annual-general-meeting no later than 3 weeks before the annual general meeting.\nFinancial Calendar 2022\nDate Event\nApril 6 Annual General Meeting\nMay 12 Q1 Earnings Release / Interim Report First \nQuarter 2022\nAugust 11 H1 Earnings Release / Interim Report First Half 2022\nNovember 10 Q3 Earnings Release / Interim Report Third Quarter 2022\nAll dates are subject to NASDAQ deadlines and reporting require-ments and are subject to changeAnalyst coverage\nZealand is followed by the financial institutions and analysts listed below:\nInstitution Analyst's name\nUSNeedham Joseph Stringer\nUnited KingdomGoldman, Sachs & Co.JefferiesKeyur ParekhPeter Welford\nNetherlandsKempen Suzanne van Voorthuizen\nDenmarkCarnegieDanske BankNordeaJesper Ils\u00f8eThomas BowersMichael Novod\nCore share data\nDenmark U.S.\nNumber of shares and ADSs at Dec. 31, 202143,634,142 1,742,842\nListing Nasdaq  CopenhagenNasdaq Global Select Market, New York\nTicker symbol ZEAL ZEAL\nIndex  membershipsNasdaq  CopenhagenSTOXX Europe TMI PharmLarge Cap40\nZealand Pharma  \u221e  Annual Report 2021", "metadata": {"source": "NASDAQ_ZEAL_2021.pdf", "page": 39, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}